WASHINGTON - While animal drug trials have been facing huge criticism from ethical groups, scientists have now created artificial organs like liver, skin, intestine and windpipe that may revolutionise the way new medicines are being tested.
Developed by Professor Heike Mertsching of the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB in Stuttgart, in collaboration with Dr. Johanna Schanz, the test system should in future give pharmaceutical companies greater security and shorten the path to new drugs.
“Our artificial organ systems are aimed at offering an alternative to animal experiments. Particularly as humans and animals have different metabolisms. 30 per cent of all side effects come to light in clinical trials,” said Mertsching.
“The special feature, in our liver model for example, is a functioning system of blood vessels. This creates a natural environment for cells,” said Schanz.
Traditional models do not have this, and the cells become inactive.
“We don’t build artificial blood vessels for this, but use existing ones - from a piece of pig’s intestine,” said Schanz.
They remove all of the pig cells, but preserve the blood vessels. Then the human cells are seeded onto hepatocytes, which are responsible for transforming and breaking down drugs, and endothelial cells, which act as a barrier between blood and tissue cells.
In order to simulate blood and circulation, the researchers put the model into a computer-controlled bioreactor with flexible tube pump, developed by the IGB.
Thus the nutrient solution is fed in and carried away in the same way as in veins and arteries in humans.
“The cells were active for up to three weeks. This time was sufficient to analyze and evaluate the functions. A longer period of activity is possible, however,” said Schanz.
The researchers concluded that the cells work in a similar way to those in the body-they detoxify, break down drugs and build up proteins.
These are important pre-conditions for drug tests or transplants, as the effect of a substance can change when transformed or broken down.
Many drugs are only metabolised into their therapeutic active form in the liver, while others can develop poisonous substances.
The researchers have demonstrated the basic possibilities for use of the tissue models - liver, skin, intestine and windpipe.
Right now, the researchers are examining the test system, which could provide a safer alternative to animal experiments within two years. (ANI)
Related News
New technique paves way for effective liver disease treatmentsOctober 10th, 2009 WASHINGTON - Scientists from University of California, San Diego have developed a novel technique that would pave way for more effective treatments for liver disease. During the study, researchers utilized an array system that can identify the biological components that can lead to or alleviate liver disease.
Artificial skin can't dodge the human touchOctober 9th, 2009 LONDON - Artificial skin covering prosthetics and humanoid robots might resemble real skin to the 'T', but when touched the difference is apparent. John-John Cabibihan at the National University of Singapore and colleagues from Italy, Norway and France, have found that fake skin responds very differently to being touched.
Synthetic hormone treatment reduces swollen liversAugust 18th, 2009 LONDON - A six-month treatment with a synthetic gastro-intestinal hormone, Lanreotide, significantly decreased swollen cystic livers, compared to a 'wait and see' policy, says a new research. At least five percent of the population have one or two cysts in the liver.
Asparagus extracts may fight hangover, protect the liverAugust 15th, 2009 WASHINGTON - Asparagus extract contains amino acids and minerals, which may ease alcohol hangover and protect liver cells against toxins, according to a study. Asparagus officinalis is a common vegetable that is widely consumed worldwide, and has long been used as an herbal medicine due to its anticancer effects.
Scientists secretly fear AI robot-machines may soon outsmart menAugust 2nd, 2009 LONDON - A robot that can open doors. Computer viruses that no one can stop.
1yr-old girl being given date-rape drug to relieve skin disease painAugust 1st, 2009 LONDON - Parents of a one-year-old baby girl have to give her a date-rape drug to ease her from the pain caused by a rare skin disease, which makes her skin as fragile as a butterfly's wing. Isla Grist's skin starts to blister and bleed with the slightest touch and she screams in pain when her bandages are changed.
Artificial sweeteners detected in German waste waterJune 18th, 2009 WASHINGTON - Scientists, using a new analytical method, have been able to demonstrate the presence of several artificial sweeteners in waste water in Germany. The method, which simultaneously extracts and analyses seven commonly used artificial sweeteners, was developed by Marco Scheurer, Heinz-Jurgen Brauch and Frank Thomas Lange from the Water Technology Center in Karlsruhe, Germany.
Novel discovery may offer improved therapies for inflammatory bowel diseaseJune 3rd, 2009 WASHINGTON - An international team of researchers has discovered an enzyme that plays a crucial role in inflammatory bowel disease (IBD). The researchers hope that the new finding could potentially lead to therapies to help those affected by ulcerative colitis and Crohn's disease, collectively referred to as IBD.
Humans 'can't distinguish pate from dog food'May 2nd, 2009 WASHINGTON - People might one day be eating dog food, for a new study has found that it tastes as good as liverwurst or duck liver mousse. The researchers found that people can't differentiate in the flavour of dog foods with that of normal human foods.
Developmental drug effective against radiation damageApril 23rd, 2009 WASHINGTON - A drug, currently under development, has been found effective in providing protection against damaging effects of radiation exposure. The research team from University of Pittsburgh School of Medicine has found that experimental drug JP4-039 protects cells from being damaged by radiation exposure.
Birds' feather's colours are synthesised in their livers, not skinsApril 16th, 2009 WASHINGTON - Contrary to previous beliefs, the red carotenoids that provide the red colouration in the Common Crossbill is synthesised in the bird's liver and not its skin, according to a new study. The findings revealed by Esther del Val, from the National History Museum in Barcelona, Spain, have implications for understanding the evolution of colour signalling in bird species.
Poor aerobic fitness linked to fatty liver diseaseApril 15th, 2009 WASHINGTON - A new study has linked low aerobic capacity to non-alcoholic fatty liver disease (NAFLD), and suggested that the resulting liver problems play a crucial step developing obesity-related illnesses. Poor aerobic fitness is already strongly associated with obesity and its consequent risks of heart disease, strokes and diabetes.
Indians living in UK and Wales at greater risk of drink-related deathMarch 20th, 2009 WASHINGTON - Men born in India, but living in England and Wales, are twice as likely to die alcohol-related deaths as the rest of the population, according to a new study led by an Indian-origin scientist. Conducted by the University of Edinburgh and the Office for National Statistics, the research also found that an equal number of alcohol-related deaths in England and Wales were reported among people born in Scotland or Ireland.
Fat synthesizing enzyme is key to healthy skin, hairFebruary 12th, 2009 WASHINGTON - Scientists have found that an enzyme associated with the synthesis of fat in the body is also the key to healthy skin and hair. The enzyme is DGAT1.
Low-carb diet burns more excess liver fatJanuary 20th, 2009 WASHINGTON - A low-carbohydrate diet burns more excess liver fat than a low-calorie diet, according to a clinical study. These findings could open the way for treating obesity and related conditions like diabetes, insulin resistance and nonalcoholic fatty liver disease (NAFLD), said Jeffrey Browning, assistant professor at the University of Texas (UT) Southwestern Advanced Imaging Research Centre.